Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention

Published:2017 Issue:11 Volume:24 Page:1125-1131
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Suwa Satoru¹,Ogita Manabu¹,Miyauchi Katsumi²,Sonoda Taketo¹,Konishi Hirokazu¹,Tsuboi Shuta¹,Wada Hideki²,Naito Ryo²,Dohi Tomotaka²,Kasai Takatoshi²,Okazaki Shinya²,Isoda Kikuo¹,Daida Hiroyuki²

Affiliation:

1. Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital

2. Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/24/11/24_38794/_pdf

Reference31 articles.

1. 1) Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994; 344: 1383-1389

2. 2) Cannon CP, Braunwald E, McCabe CH, Rada DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM, for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarctioni 22 Investigators: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Eng J Med, 2004; 350: 1495-1504